abstract |
The present invention relates to benzoxazole derivatives having the formula (I). It has been found that the compounds of the present invention have the ability to reduce PD-L1 levels, suggesting that the compounds of the invention may be used in the treatment or prevention of cancer immunotherapy and sepsis or septic shock. |